A recent clinical trial found that taking a moderate daily dose of vitamin D during chemotherapy may help eliminate breast cancer tumors before surgery. The study, published in April 2026, enrolled 80 women aged 45 and older who were diagnosed with breast cancer and scheduled to receive neoadjuvant chemotherapy, a treatment given before surgery to shrink tumors.
Vitamin D and Chemotherapy
Participants were randomly assigned to take either 2,000 IU of vitamin D daily or a placebo for six months while undergoing chemotherapy. Vitamin D is known to play a role in bone health, but it also influences immune function and cellular processes involved in cancer. Breast tissue contains vitamin D receptors that, when activated, can slow tumor growth and promote cancer cell death.
Study Findings
After completing chemotherapy and surgery, 43% of women who took vitamin D achieved a pathological complete response, meaning no detectable cancer remained in breast tissue. In the placebo group, only 24% reached that result. The rate of tumor eradication before surgery nearly doubled among those who supplemented with vitamin D.
Researchers also measured blood levels of vitamin D. Women with levels above 20 ng/mL were more than three times as likely to have a complete tumor response, regardless of other clinical factors. This suggests that even moderate vitamin D sufficiency may improve chemotherapy effectiveness.
Possible Reasons for the Effect
Vitamin D influences genes that control cell growth, programmed cell death, and the spread of tumors. It may also make cancer cells more responsive to chemotherapy drugs such as anthracyclines and taxanes, which are commonly used in breast cancer treatment. Earlier studies have indicated that vitamin D can increase cancer cell sensitivity to these drugs and enhance their tumor-killing effects.
Many breast cancer patients, especially postmenopausal women, have low vitamin D levels at the time of diagnosis. Low levels may weaken the body’s response to treatment. Chemotherapy itself can further reduce vitamin D levels by limiting sun exposure and affecting metabolism. Supplementing during treatment may help offset that drop.
What This Means for Patients
Taking a safe, widely available supplement of 2,000 IU of vitamin D daily during chemotherapy could be a simple strategy to improve treatment outcomes. The trial was small and conducted at a single center, but its randomized design strengthens the evidence that vitamin D supplementation may help patients achieve better tumor control.
More research is needed to confirm these findings in larger and more diverse groups and to determine the best dose. Because vitamin D is affordable and safe at recommended levels, adding it to breast cancer care for patients with low levels may be a practical step.
The study adds to growing evidence that maintaining adequate vitamin D status could support more successful cancer treatment. For many patients, a daily vitamin D supplement may do more than keep bones strong.
